Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,449 | -1,283 | -3,962 | -2,285 | 669 |
| Depreciation Amortization | 2,696 | 2,343 | 2,413 | 1,553 | 1,300 |
| Income taxes - deferred | 156 | 104 | -5 | 262 | 113 |
| Accounts receivable | -2,112 | -151 | -476 | 1,557 | -1,017 |
| Accounts payable and accrued liabilities | 369 | -367 | -242 | 1,302 | 65 |
| Other Working Capital | -1,936 | -298 | -5,238 | 556 | -664 |
| Other Operating Activity | 2,986 | 2,307 | 2,766 | -1,577 | 1,533 |
| Operating Cash Flow | $-291 | $2,654 | $-4,744 | $1,368 | $1,999 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -635 | -205 | -471 | -489 | -917 |
| Net Acquisitions | N/A | N/A | -121 | -13,738 | -6,770 |
| Purchase Sale Intangibles | -2,250 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2,250 | 0 | 1,193 | 0 | 0 |
| Investing Cash Flow | $-2,885 | $-205 | $601 | $-14,227 | $-7,687 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 769 | -1,140 | 2,227 | 1,219 | -1,081 |
| Debt Issued | N/A | N/A | N/A | 6,000 | 1,000 |
| Debt Repayment | -4,059 | -1,298 | -1,314 | -500 | -1,296 |
| Common Stock Issued | 4,491 | -5 | 5,728 | 5,611 | 7,282 |
| Other Financing Activity | 2,032 | -324 | -2,284 | -434 | -49 |
| Financing Cash Flow | $3,233 | $-2,767 | $4,358 | $11,896 | $5,856 |
| Exchange Rate Effect | 104 | 170 | -402 | 253 | 12 |
| Beginning Cash Position | 244 | 391 | 577 | 1,286 | 1,105 |
| End Cash Position | 404 | 244 | 391 | 577 | 1,286 |
| Net Cash Flow | $161 | $-148 | $-186 | $-709 | $181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -291 | 2,654 | -4,744 | 1,368 | 1,999 |
| Capital Expenditure | -635 | -266 | -471 | -491 | -932 |
| Free Cash Flow | -926 | 2,389 | -5,215 | 877 | 1,067 |